Xortx Therapeutics is now in the thick of things. The FDA has granted the company’s drug candidate the right to accelerated approval. Now the market is waiting for a licensing deal and the start of the decisive phase III with a partner. Xortx Therapeutics: Drug …
Read More »Xortx Therapeutics: Now it’s time for the final spurt!
